Trials / Unknown
UnknownNCT05390073
Growth Hormone in EB
Assessment of Growth Hormone and Insulin-like Growth Factor 1 in Children With Epidermolysis Bullosa Dystrophia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 1 Month – 12 Years
- Healthy volunteers
- —
Summary
Growth is extremely affected in epidermolysis bullosa patients
Detailed description
Studying the role of growth hormone and ILGF-1 in EB may pave the to new therapeutic modality that could improve the growth in those children and avoid the irreversible sequelae that affected subjects experience after adulthood
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | growth hormone level and insulin like growth factor 1 | laboratory test |
Timeline
- Start date
- 2022-05-25
- Primary completion
- 2022-06-10
- Completion
- 2022-06-15
- First posted
- 2022-05-25
- Last updated
- 2022-05-25
Source: ClinicalTrials.gov record NCT05390073. Inclusion in this directory is not an endorsement.